
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More